Read news as it happens
Create a Rediffmail account
Get Rediff News delivered into your Inbox daily
Why US FDA is cracking down on India's shrimp shipments
US, the largest market for Indian shrimp exporters, is peeved over the use of banned antibiotics.
Sun Pharma's m-cap sinks by Rs 8,736 crore in just one day
The stock was the worst hit among the blue-chips on both BSE and NSE.
Fisticuffs in Fortis family as Singhs accuse each other of assault
The relationship between the Singh brothers, erstwhile promoters of Fortis Healthcare, went sour after allegations of...
Whistle-blower prods Sebi to probe Sun Pharma
Sebi, according to sources, also plans to reopen an insider trading case against the company and its promoters that...
Unfazed by legal blocks, Netmeds bets big on digital
Netmeds is looking at using new technologies such as deep learning and data analytics to improve forecasting in terms...
Why 1,700 employees of Pfizer's India arm may lose their jobs
A key lesson for the pharmaceutical sector in this case is to not downplay the significant impact that regulatory...
As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days
Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a...
In just 4 years, Sun Pharma's Dilip Shanghvi lost wealth over 60%
Around March 2015, Shanghvi became the richest Indian for a brief period, surpassing Reliance Industries' Mukesh...
Lessons from the Fortis/Raymond family feuds
'Nothing in this world is permanent. So also in business.' 'And more so in family businesses where family issues...
HUL-GlaxoSmithKline merger leads to Rs 31,700 cr entity
The transaction is an all equity merger with 4.39 shares of HUL being allotted for every share in GlaxoSmithKline...
Office email App
© 2019 Rediff.com